Copyright Reports & Markets. All rights reserved.

Global Specialty Generics Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Specialty Generics Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Specialty Generics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Injectables
    • 1.4.3 Oral
    • 1.4.4 Others
  • 1.5 Market by Application
    • 1.5.1 Global Specialty Generics Market Share by Application: 2020 VS 2026
    • 1.5.2 Oncology
    • 1.5.3 Inflammatory Conditions
    • 1.5.4 Multiple Sclerosis
    • 1.5.5 Hepatitis C
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Specialty Generics Market Perspective (2015-2026)
  • 2.2 Global Specialty Generics Growth Trends by Regions
    • 2.2.1 Specialty Generics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Specialty Generics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Specialty Generics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Specialty Generics Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Specialty Generics Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Specialty Generics Players by Market Size
    • 3.1.1 Global Top Specialty Generics Players by Revenue (2015-2020)
    • 3.1.2 Global Specialty Generics Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Specialty Generics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Specialty Generics Market Concentration Ratio
    • 3.2.1 Global Specialty Generics Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Specialty Generics Revenue in 2019
  • 3.3 Specialty Generics Key Players Head office and Area Served
  • 3.4 Key Players Specialty Generics Product Solution and Service
  • 3.5 Date of Enter into Specialty Generics Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Specialty Generics Historic Market Size by Type (2015-2020)
  • 4.2 Global Specialty Generics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Specialty Generics Market Size by Application (2015-2020)
  • 5.2 Global Specialty Generics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Specialty Generics Market Size (2015-2020)
  • 6.2 Specialty Generics Key Players in North America (2019-2020)
  • 6.3 North America Specialty Generics Market Size by Type (2015-2020)
  • 6.4 North America Specialty Generics Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Specialty Generics Market Size (2015-2020)
  • 7.2 Specialty Generics Key Players in Europe (2019-2020)
  • 7.3 Europe Specialty Generics Market Size by Type (2015-2020)
  • 7.4 Europe Specialty Generics Market Size by Application (2015-2020)

8 China

  • 8.1 China Specialty Generics Market Size (2015-2020)
  • 8.2 Specialty Generics Key Players in China (2019-2020)
  • 8.3 China Specialty Generics Market Size by Type (2015-2020)
  • 8.4 China Specialty Generics Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Specialty Generics Market Size (2015-2020)
  • 9.2 Specialty Generics Key Players in Japan (2019-2020)
  • 9.3 Japan Specialty Generics Market Size by Type (2015-2020)
  • 9.4 Japan Specialty Generics Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Specialty Generics Market Size (2015-2020)
  • 10.2 Specialty Generics Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Specialty Generics Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Specialty Generics Market Size by Application (2015-2020)

11 India

  • 11.1 India Specialty Generics Market Size (2015-2020)
  • 11.2 Specialty Generics Key Players in India (2019-2020)
  • 11.3 India Specialty Generics Market Size by Type (2015-2020)
  • 11.4 India Specialty Generics Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Specialty Generics Market Size (2015-2020)
  • 12.2 Specialty Generics Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Specialty Generics Market Size by Type (2015-2020)
  • 12.4 Central & South America Specialty Generics Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Teva Pharmaceuticals USA, Inc.
    • 13.1.1 Teva Pharmaceuticals USA, Inc. Company Details
    • 13.1.2 Teva Pharmaceuticals USA, Inc. Business Overview
    • 13.1.3 Teva Pharmaceuticals USA, Inc. Specialty Generics Introduction
    • 13.1.4 Teva Pharmaceuticals USA, Inc. Revenue in Specialty Generics Business (2015-2020))
    • 13.1.5 Teva Pharmaceuticals USA, Inc. Recent Development
  • 13.2 Mylan N.V.
    • 13.2.1 Mylan N.V. Company Details
    • 13.2.2 Mylan N.V. Business Overview
    • 13.2.3 Mylan N.V. Specialty Generics Introduction
    • 13.2.4 Mylan N.V. Revenue in Specialty Generics Business (2015-2020)
    • 13.2.5 Mylan N.V. Recent Development
  • 13.3 Sandoz International GmbH
    • 13.3.1 Sandoz International GmbH Company Details
    • 13.3.2 Sandoz International GmbH Business Overview
    • 13.3.3 Sandoz International GmbH Specialty Generics Introduction
    • 13.3.4 Sandoz International GmbH Revenue in Specialty Generics Business (2015-2020)
    • 13.3.5 Sandoz International GmbH Recent Development
  • 13.4 Akorn, Inc.
    • 13.4.1 Akorn, Inc. Company Details
    • 13.4.2 Akorn, Inc. Business Overview
    • 13.4.3 Akorn, Inc. Specialty Generics Introduction
    • 13.4.4 Akorn, Inc. Revenue in Specialty Generics Business (2015-2020)
    • 13.4.5 Akorn, Inc. Recent Development
  • 13.5 Mallinckrodt
    • 13.5.1 Mallinckrodt Company Details
    • 13.5.2 Mallinckrodt Business Overview
    • 13.5.3 Mallinckrodt Specialty Generics Introduction
    • 13.5.4 Mallinckrodt Revenue in Specialty Generics Business (2015-2020)
    • 13.5.5 Mallinckrodt Recent Development
  • 13.6 Valeant Pharmaceuticals International, Inc.
    • 13.6.1 Valeant Pharmaceuticals International, Inc. Company Details
    • 13.6.2 Valeant Pharmaceuticals International, Inc. Business Overview
    • 13.6.3 Valeant Pharmaceuticals International, Inc. Specialty Generics Introduction
    • 13.6.4 Valeant Pharmaceuticals International, Inc. Revenue in Specialty Generics Business (2015-2020)
    • 13.6.5 Valeant Pharmaceuticals International, Inc. Recent Development
  • 13.7 Pfizer Inc.
    • 13.7.1 Pfizer Inc. Company Details
    • 13.7.2 Pfizer Inc. Business Overview
    • 13.7.3 Pfizer Inc. Specialty Generics Introduction
    • 13.7.4 Pfizer Inc. Revenue in Specialty Generics Business (2015-2020)
    • 13.7.5 Pfizer Inc. Recent Development
  • 13.8 Endo Pharmaceuticals Inc.
    • 13.8.1 Endo Pharmaceuticals Inc. Company Details
    • 13.8.2 Endo Pharmaceuticals Inc. Business Overview
    • 13.8.3 Endo Pharmaceuticals Inc. Specialty Generics Introduction
    • 13.8.4 Endo Pharmaceuticals Inc. Revenue in Specialty Generics Business (2015-2020)
    • 13.8.5 Endo Pharmaceuticals Inc. Recent Development
  • 13.9 Apotex Corp.
    • 13.9.1 Apotex Corp. Company Details
    • 13.9.2 Apotex Corp. Business Overview
    • 13.9.3 Apotex Corp. Specialty Generics Introduction
    • 13.9.4 Apotex Corp. Revenue in Specialty Generics Business (2015-2020)
    • 13.9.5 Apotex Corp. Recent Development
  • 13.10 Sun Pharmaceutical Industries Ltd.
    • 13.10.1 Sun Pharmaceutical Industries Ltd. Company Details
    • 13.10.2 Sun Pharmaceutical Industries Ltd. Business Overview
    • 13.10.3 Sun Pharmaceutical Industries Ltd. Specialty Generics Introduction
    • 13.10.4 Sun Pharmaceutical Industries Ltd. Revenue in Specialty Generics Business (2015-2020)
    • 13.10.5 Sun Pharmaceutical Industries Ltd. Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Specialty Generics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Specialty Generics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Teva Pharmaceuticals USA, Inc.
    Mylan N.V.
    Sandoz International GmbH
    Akorn, Inc.
    Mallinckrodt
    Valeant Pharmaceuticals International, Inc.
    Pfizer Inc.
    Endo Pharmaceuticals Inc.
    Apotex Corp.
    Sun Pharmaceutical Industries Ltd.

    Market segment by Type, the product can be split into
    Injectables
    Oral
    Others
    Market segment by Application, split into
    Oncology
    Inflammatory Conditions
    Multiple Sclerosis
    Hepatitis C

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now